New Phase 2 clinical trials: 7,214 posted since Nov 2024

Name: New Phase 2 clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Phase 2 clinical trials: 7,214 rows for $152.14, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 314 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/phase/phase-2, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

7,214 clinical studies in phase 2 were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 2,090 have an industry sponsor and 5,959 are recruiting or about to. The newest, NCT07927036, was posted on November 9, 2026: Enhancing the Effect of Stellate Ganglion Block in the Treatment of Posttraumatic Stress Disorder: A... (The Royal's Institute of Mental Health Research).

The request: Every new Phase 2 clinical trials on ClinicalTrials.gov, with the sponsor, conditions, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

7,214New trials
2,090Industry sponsored
5,959Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 7,214, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07927036	Enhancing the Effect of Stellate Ganglion Block in the Treatment of Posttraumatic Stress Disorder: A Double-blind Randomized Controlled...	The Royal's Institute of Mental Health Research	Phase 2	Not yet recruiting	Posttraumatic Stress Disorder (PTSD)	126	Canada	clinicaltrials.gov
November 9, 2026	NCT07926698	Lanoracopan to Prevent Acute GVHD Following Haploidentical Peripheral Blood Stem Cell Transplantation: A Prospective Multicenter Single-Arm...	The First Affiliated Hospital of Soochow University	Phase 2	Not yet recruiting	Hematologic Malignancies, Haploidentical Peripheral Blood Stem Cell Transplantation, Acute Graft-Versus-Host Disease	30		clinicaltrials.gov
November 9, 2026	NCT07926477	Trastuzumab Rezetecan + Bevacizumab vs. TAS-102 + Bevacizumab in Pretreated mCRC With HER2 Low/Moderate Expression or HER2 Positivity With...	Second Affiliated Hospital, Zhejiang University, School of Medicine	Phase 2	Not yet recruiting	Colorectal Cancer	86		clinicaltrials.gov
November 9, 2026	NCT07926321	A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment	Boehringer Ingelheim	Phase 2	Not yet recruiting	Idiopathic Pulmonary Fibrosis	70	Belgium, Finland, Germany, Japan, Mexico, South Korea, Spain, United States	clinicaltrials.gov
November 9, 2026	NCT07926282	Adjunctive Melatonin Gel With MINST on GCF Galectin-3 and IL-1 in Stage III-IV Periodontitis	Badr University	Phase 2	Not yet recruiting	Periodontitis, Periodontitis (Stage 3), Periodontitis Stage IV	40		clinicaltrials.gov
November 9, 2026	NCT07926217	High-Dose Versus Standard-Dose Influenza Vaccine in Patients With Hematologic Malignancies Receiving B-Cell-Depleting Therapy	Sung-Han Kim	Phase 2	Recruiting	Hematologic Malignancy, Influenza	60	South Korea	clinicaltrials.gov
November 9, 2026	NCT07925866	Tislelizumab Combined With Tofacitinib and Docetaxel for NSCLC After Failure of First-Line Immunotherapy	Anhui Provincial Hospital	Phase 2	Recruiting	Patients With Locally Advanced or Metastatic NSCLC Who Have Failed First-line Immunotherapy	39	China	clinicaltrials.gov
November 9, 2026	NCT07925619	Efficacy and Safety Study of L608 in Patients With Systemic Sclerosis-associated Digital Ulcers	Pharmosa Biopharm Inc.	Phase 2	Not yet recruiting	Systemic Sclerosis	40		clinicaltrials.gov
November 9, 2026	NCT07925554	Interferon-α Maintenance in Favorable-Risk AML	Peking University People's Hospital	Phase 2	Recruiting	AML (Acute Myeloid Leukemia)	30	China	clinicaltrials.gov
November 9, 2026	NCT07925333	Lifileucel (TIL) Therapy After PD-1 Blockade Failure in Kidney Cancer	Beth Israel Deaconess Medical Center	Phase 2	Not yet recruiting	Kidney Cancers, Renal Cell Carcinoma (Kidney Cancer)	10	United States	clinicaltrials.gov
November 9, 2026	NCT07925268	Study of Ifinatamab Deruxtecan in De Novo or Treatment-Emergent Neuroendocrine Prostate Cancer	Rahul Aggarwal	Phase 2	Not yet recruiting	Neuroendocrine Prostate Cancer (NEPC), Metastatic Prostate Adenocarcinoma, Prostate Cancer	30	United States	clinicaltrials.gov
November 9, 2026	NCT07925242	FAPI PET in Systemic Sclerosis Interstitial Lung Disease	University of California, Los Angeles	Phase 2	Not yet recruiting	Systemic Sclerosis (SSc), Scleroderma, Interstitial Lung Disease With Systemic Sclerosis	120	United States	clinicaltrials.gov
November 9, 2026	NCT07924722	Local Iloprost Therapy to Promote Bone Healing in High Risk Fractures	Charite University, Berlin, Germany	Phase 2	Not yet recruiting	Nonunion Bone Fracture, Fractures Ununited, Fractures	60		clinicaltrials.gov
November 9, 2026	NCT07924605	PSMA PET/MRI for Predicting and Detecting Prostate Cancer	University of Wisconsin, Madison	Phase 2	Not yet recruiting	Prostate Cancer, High-Risk Localized Prostate Cancer, Locally Advanced Prostate Cancer, Low-Risk Prostate Cancer...	120	United States	clinicaltrials.gov
November 9, 2026	NCT07924332	Retlirafusp Alfa or Adebrelimab Plus SOX as Neoadjuvant Therapy for HER2-Negative Resectable Gastric or Gastroesophageal Junction...	Qun Zhao	Phase 2	Not yet recruiting	Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma	98		clinicaltrials.gov
November 9, 2026	NCT07923877	Induction Chemoimmunotherapy to Prevent Laryngectomy in Advanced Laryngeal Cancer and Hypopharyngeal Cancer	Mayo Clinic	Phase 2	Not yet recruiting	Advanced Laryngeal Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Stage III Laryngeal Cancer AJCC v8...	50	United States	clinicaltrials.gov
November 6, 2026	NCT07923851	A Trial Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Palmoplantar Pustulosis	Guangdong Hengrui Pharmaceutical Co., Ltd	Phase 2	Not yet recruiting	Palmoplantar Pustulosis of Adults	40	China	clinicaltrials.gov
November 6, 2026	NCT07923773	Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)	Novartis Pharmaceuticals	Phase 2	Not yet recruiting	Moderate to Severe Psoriatic Arthritis	88		clinicaltrials.gov
November 6, 2026	NCT07923760	Supplemental Oxygen for Sleep-Disordered Breathing in Adults With Chronic Opioid Use.	University of California, San Diego	Phase 2	Not yet recruiting	Sleep-disordered Breathing, Chronic Opioid Use	62	United States	clinicaltrials.gov
November 6, 2026	NCT07923630	Validation & Intervention Testing for Aging, Longevity and Healthspan	The University of Texas Health Science Center at San Antonio	Phase 2	Not yet recruiting	Aging, Functional Decline	1,200	United States	clinicaltrials.gov
November 6, 2026	NCT07923617	Lisdexamfetamine For the Treatment of Conduct Disorder in Children	Orygen	Phase 2	Not yet recruiting	Conduct Disorder	30		clinicaltrials.gov
November 6, 2026	NCT07923591	Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic...	United Therapeutics	Phase 2	Not yet recruiting	Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease	40	United States	clinicaltrials.gov
November 6, 2026	NCT07923448	Can TrenibotulinumtoxinE Reverse OnabotulinumtoxinA Effect in Treating Lateral Canthal Lines?	Project Skin MD	Phase 2	Not yet recruiting	Wrinkles and Rhytides	4		clinicaltrials.gov
November 6, 2026	NCT07923357	A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus	Shenzhen Salubris Pharmaceuticals Co., Ltd.	Phase 2	Not yet recruiting	Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, T2DM	364	China	clinicaltrials.gov
November 6, 2026	NCT07922928	Toripalimab and Lenvatinib With or Without SBRT Before Surgery for Non-Clear Cell Kidney Cancer	Sun Yat-sen University	Phase 2	Not yet recruiting	Nonmetastatic Locally Advanced Non-Clear Cell Renal Cell Carcinoma	36		clinicaltrials.gov
November 6, 2026	NCT07922915	Pucotenlimab, Lenvatinib, and SBRT Before Surgery for Localized Clear Cell Renal Cell Carcinoma	Sun Yat-sen University	Phase 2	Not yet recruiting	Localized Clear Cell Renal Cell Carcinoma	24		clinicaltrials.gov
November 6, 2026	NCT07922616	Intralesional Metformin Versus Triamcinolone for Keloid Treatment	Al-Azhar University	Phase 2	Completed	Keloids	30	Egypt	clinicaltrials.gov
November 6, 2026	NCT07922148	Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized...	Beckey Trinh	Phase 2	Not yet recruiting	Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)	44	Switzerland	clinicaltrials.gov
November 6, 2026	NCT07921615	QLS4131 Plus Isa-V-CHOP in Newly Diagnosed, HIV-Negative PBL: A Single-Center, Single-Arm, Phase II Study	Institute of Hematology & Blood Diseases Hospital, China	Phase 2	Not yet recruiting	Plasmablastic Lymphoma	10		clinicaltrials.gov
November 6, 2026	NCT07921420	MF-300 for Treatment of Age-Related Sarcopenia	Epirium Bio Inc.	Phase 2	Not yet recruiting	Sarcopenia in Elderly	225		clinicaltrials.gov
November 6, 2026	NCT07921355	Melatonin in Posterior Mandible Extraction Socket	Cairo University	Phase 2	Not yet recruiting	Bone Loss	40		clinicaltrials.gov
November 6, 2026	NCT07921082	Effectiveness of Oxitard Gel Versus Physiotherapeutic and Pharmacological Interventions in Alleviating Oral Submucous Fibrosis: A Phase-II...	Dow University of Health Sciences	Phase 2	Not yet recruiting	Oral and Maxillofacial Conditions	20	Pakistan	clinicaltrials.gov
November 6, 2026	NCT07920887	A Study of Bimagrumab in Participants With HFpEF	Eli Lilly and Company	Phase 2	Not yet recruiting	Heart Failure, Diastolic, Diastolic Heart Failure, Heart Failure, Normal Ejection Fraction, Heart Failure, Preserved...	540	Hungary, Italy, Poland, United States	clinicaltrials.gov
November 6, 2026	NCT07920835	A Multicenter Phase II Clinical Trial Evaluating 68Ga-HX01 Injection for PET/CT Imaging	Hexin (Suzhou) Pharmaceutical Technology Co., Ltd	Phase 2	Recruiting	Soft Tissue Sarcoma	60	China	clinicaltrials.gov
November 6, 2026	NCT07920796	Thiotepa + TBI + Fludarabine + Etoposide for Allo-HSCT in Patients With R/R or High-risk Acute Leukemia	Guangdong Second Provincial General Hospital	Phase 2	Enrolling by invitation	Acute Leukemia, High Risk, Acute Leukemia Refractory, Acute Leukemia, Relapsed	50	China	clinicaltrials.gov
November 6, 2026	NCT07920731	A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer	Fudan University	Phase 2	Enrolling by invitation	Pancreatic Cancer Metastatic	45	China	clinicaltrials.gov
November 5, 2026	NCT07920640	Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle Intervention	Beijing Supreme Life Pharmaceutical Technology Co., Ltd.	Phase 2	Not yet recruiting	Diabetes Mellitus, Type 2	150	China	clinicaltrials.gov
November 5, 2026	NCT07920393	Allogeneic Cell Therapy in Refractory T-Cell Lymphoma	University Medical Center Goettingen	Phase 2	Not yet recruiting	Lymphoma, T Cell, Peripheral	70		clinicaltrials.gov
November 5, 2026	NCT07920250	Pre-Radiotherapy n-6/n-3 Fatty Acid Ratio Predicts Severe Oral Mucositis in Nasopharyngeal Carcinoma	Affiliated Hospital of Guangdong Medical University	Phase 2	Completed	Nasopharyngeal Carcinoma (NPC), Radiation-induced Oral Mucositis, Head and Neck Neoplasms	210	China	clinicaltrials.gov
November 5, 2026	NCT07920224	Candonilimab Combined With Fruquintinib and Paclitaxel Albumin-Bound as Second-Line Treatment for Advanced Gastric or Gastro-esophageal...	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2	Recruiting	Stomach Neoplasms	59	China	clinicaltrials.gov
November 5, 2026	NCT07920185	A Study of Oral SOM001 as a Safe and Effective Treatment for Adults With Chronic Insomnia in a Randomized, Controlled, Dose-finding Study	Somnum Pharma Inc.	Phase 2	Not yet recruiting	Chronic Insomnia	45	United States	clinicaltrials.gov
November 5, 2026	NCT07920159	Study of Suvemcitug Plus Chemotherapy in Advanced High-Grade Serous Ovarian Cancer	Anhui Provincial Hospital	Phase 2	Not yet recruiting	High-grade Serous Ovarian Cancer	76		clinicaltrials.gov
November 5, 2026	NCT07919977	Romiplostim for Platelet Engraftment After Haploidentical or Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation	Liping Dou	Phase 2	Recruiting	Hematologic Diseases	120	China	clinicaltrials.gov
November 5, 2026	NCT07919821	Early Feeding TL Trial	University of Florida	Phase 2	Not yet recruiting	Total Laryngectomy	120	United States	clinicaltrials.gov
November 5, 2026	NCT07919717	NIVO+IPI Neoadjuvant Therapy for Recurrent Resectable HCC	Shanghai Zhongshan Hospital	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC), Recurrent Hepatocellular Cancer	35	China	clinicaltrials.gov
November 5, 2026	NCT07919691	Proton Moderately Hypofractionated Radiotherapy in NSCLC Patients Unable to Tolerate Standard Concurrent Chemoradiotherapy	Ruijin Hospital	Phase 2	Not yet recruiting	Non-Small Cell Lung Cancer	44		clinicaltrials.gov
November 5, 2026	NCT07919457	Phenotype-based Model for Managing Chronic Post-treatment Pain Among Head and Neck Cancer Survivors: a Pilot Study	Shaukat Khanum Memorial Cancer Hospital & Research Centre	Phase 2	Recruiting	Chronic Postsurgical Pain, Chronic Post Cancer Surgery Pain, Chronic Post Operative Pain, Radiation Effects...	40	Pakistan	clinicaltrials.gov
November 5, 2026	NCT07919444	Effectiveness of Phenotype-based Pain Management Guidelines for Head and Neck Cancer Related Pain: a Pilot Study	Shaukat Khanum Memorial Cancer Hospital & Research Centre	Phase 2	Recruiting	Cancer Pain, Orofacial Pain, Head and Neck Cancer, Head and Neck (HNSCC)	40	Pakistan	clinicaltrials.gov
November 5, 2026	NCT07918989	A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After...	Memorial Sloan Kettering Cancer Center	Phase 2	Recruiting	Breast Cancer, Breast Cancer Female	138	United States	clinicaltrials.gov
November 5, 2026	NCT07918976	Effects of Inhaled Nitric Oxide on Sublingual Microcirculation in Patients With Right Ventricular Dysfunction After Cardiac Surgery	Southeast University, China	Phase 2	Completed	Cardiac Surgery Intensive Care Treatment, Pulmonary Hypertension, Right Ventricular (RV) Dysfunction	60	China	clinicaltrials.gov
November 5, 2026	NCT07918625	A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes	BrightGene Bio-Medical Technology Co., Ltd.	Phase 2	Not yet recruiting	Overweight or Obese Participants Without Diabetes	160	China	clinicaltrials.gov
November 5, 2026	NCT07918573	Telacebec in Adults With Multibacillary Leprosy (TEBULA Leprosy Trial)	Fondation Raoul Follereau	Phase 2	Not yet recruiting	Leprosy, Multibacillary	120	Benin	clinicaltrials.gov
November 5, 2026	NCT07918274	Restoring Awareness	Casa Colina Hospital and Centers for Healthcare	Phase 2	Not yet recruiting	Vegetative State, Minimally Conscious State	24		clinicaltrials.gov
November 5, 2026	NCT07918079	Netupitant/Palonosetron for Prevention of Nausea and Vomiting in Breast Cancer ADC Therapy	Fudan University	Phase 2	Not yet recruiting	Breast Cancer	84		clinicaltrials.gov
November 5, 2026	NCT07917949	Zemetostat With Anlotinib in Patients With Recurrent/Metastatic Head and Neck Soft Tissue Sarcoma	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University	Phase 2	Recruiting	Soft Tissue Sarcoma	34	China	clinicaltrials.gov
November 5, 2026	NCT07917910	A Study of HT-101 and HT-102 in Chronic Hepatitis B (CHB)	Suzhou HepaThera Biotech Co., Ltd.	Phase 2	Not yet recruiting	Chronic Hepatitis B Virus Infection	120		clinicaltrials.gov
November 5, 2026	NCT07917832	Smart 3: A Multi-Center Phase 2 Trial Of Golcadomide, Glofitamab And Polatuzumab Vedotin (G2P) For Patients With Newly Diagnosed Large...	M.D. Anderson Cancer Center	Phase 2	Not yet recruiting	Multi Center, Phase 2, Golcadomide, Glofitamab, Polauzumab, Vedotin, G2p, B Cell Lymphoma	60	United States	clinicaltrials.gov
November 5, 2026	NCT07917780	A Prospective, Open-label, Randomized, Multicenter Phase-III Trial to Evaluate the Efficacy of Pirtobrutinib and Epcoritamab Compared With...	German CLL Study Group	Phase 2	Recruiting	Richter Transformation	116	Australia, Austria, Denmark, Germany, Ireland	clinicaltrials.gov
November 5, 2026	NCT07917767	A Prospective Cohort Study of PD-1 Monoclonal Antibody Combined With Ipilimumab N01 and Chemotherapy in Perioperative Treatment of...	Tang-Du Hospital	Phase 2	Not yet recruiting	NSCLC Stage IIIA/B, NSCLC Stage II	90		clinicaltrials.gov
November 4, 2026	NCT07917650	PET/CT-Guided Maintenance Therapy in Previously Untreated MZL	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2	Active not recruiting	Marginal Zone Lymphoma(MZL)	45	China	clinicaltrials.gov
November 4, 2026	NCT07917624	Prophylactic Strategies for Mitigating Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2	Not yet recruiting	Diffuse Large B-Cell Lymphoma (DLBCL)	87	China	clinicaltrials.gov
November 4, 2026	NCT07917481	A Clinical Study Evaluating the Safety and Efficacy of Ivonescimab as Second-line Treatment in Patients With Advanced Hepatocellular...	MedSIR	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC), HCC - Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma (HCC)	44		clinicaltrials.gov
November 4, 2026	NCT07917338	Oral N-Acetylcysteine on Diabetic Macular Edema	Khadija Ahmed Mhrose Glal	Phase 2	Recruiting	Diabetic Macular Edema (DME)	50	Egypt	clinicaltrials.gov
November 4, 2026	NCT07917104	Circulating Tumor DNA Methylation-Guided Adjuvant Therapy Decision-Making in Patients With Resectable Colorectal Cancer Liver Metastases...	Fudan University	Phase 2	Recruiting	Colorectal Cancer Liver Metastases (CRLM), ctDNA	220	China	clinicaltrials.gov
November 4, 2026	NCT07917039	SYH2072 Tablets in Participants With Primary Aldosteronism	InnovStone Therapeutics Limited	Phase 2	Not yet recruiting	Primary Aldosteronism	60	China	clinicaltrials.gov
November 4, 2026	NCT07916740	Autologous Hair Follicle-Derived Secretome and Platelet-Rich Plasma for Premature Ovarian Insufficiency	Trio Fertility	Phase 2	Recruiting	Premature Ovarian Insufficiency, POI, Primary Ovarian Insufficiency (Poi), Premature Ovarian Failure (POF)	15	Canada	clinicaltrials.gov
November 4, 2026	NCT07916389	Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric Glioma	St. Jude Children's Research Hospital	Phase 2	Not yet recruiting	Infant-Type Hemispheric Glioma	50	United States	clinicaltrials.gov
November 4, 2026	NCT07916324	Hyaluronidase Injections for Sclerodactyly in Patients With Scleroderma	Stanford University	Phase 2	Not yet recruiting	Scleroderma, Sclerodactyly, Systemic Sclerosis	10	United States	clinicaltrials.gov
November 4, 2026	NCT07915791	A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe...	GlaxoSmithKline	Phase 2	Not yet recruiting	Pulmonary Disease, Chronic Obstructive	279		clinicaltrials.gov
November 4, 2026	NCT07915687	Synbiotic as an Adjuvant Therapy for Dyslipidaemia and Gut Health	Universiti Teknologi Mara	Phase 2	Not yet recruiting	Dyslipidemia	190	Malaysia	clinicaltrials.gov
November 4, 2026	NCT07915258	Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Head and Neck Squamous Cell Carcinoma With Suboptimal Response to Induction...	Sun Yat-sen University	Phase 2	Not yet recruiting	Squamous Cell Carcinoma of Head and Neck (SCCHN)	22	China	clinicaltrials.gov
November 4, 2026	NCT07914855	Testing the Anti-cancer Drug DSP-5336 (Enzomenib) in Prostate Cancer	National Cancer Institute (NCI)	Phase 2	Not yet recruiting	Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8	24		clinicaltrials.gov
November 4, 2026	NCT07914816	Phase 2 Evaluation of Recombinant Human Platelet-Derived Growth Factor-BB (rhPDGF-BB) Injection for the Treatment of Infraorbital Hollowing	Lynch Regenerative Medicine	Phase 2	Not yet recruiting	Infra-orbital Hollows, Skin Quality Improvement	75	United States	clinicaltrials.gov
November 3, 2026	NCT07914660	Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)	Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.	Phase 2	Not yet recruiting	Hyperlipoproteinemia (a)	192	China	clinicaltrials.gov
November 3, 2026	NCT07914647	Remote Ischaemic Conditioning for Fatigue After Stroke 2 (RICFAST 2)	Sheffield Teaching Hospitals NHS Foundation Trust	Phase 2	Recruiting	Stroke, Fatigue	60	United Kingdom	clinicaltrials.gov
November 3, 2026	NCT07914309	Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer	Washington University School of Medicine	Phase 2	Not yet recruiting	Triple Negative Breast Cancer, Triple Negative Breast Cancer (TNBC), Breast Cancer	17	United States	clinicaltrials.gov
November 3, 2026	NCT07914231	A Study to Assess the Safety and Effectiveness of COL-5671-PRO Capsules in Adults With Moderate-to-Severe Plaque Psoriasis	Coultreon Biopharma	Phase 2	Not yet recruiting	Plaque Psoriasis	100	Canada	clinicaltrials.gov
November 3, 2026	NCT07914088	A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis	Arjil Pharmaceuticals LLC	Phase 2	Recruiting	Dermatitis Atopic	40	Taiwan	clinicaltrials.gov
November 3, 2026	NCT07914062	PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine Correlates	Antev Ltd.	Phase 2	Not yet recruiting	Endometriosis Pelvic, Endometriosis Ovaries, Premenopausal, Endometriosis (Diagnosis), Dysmenorrhoea, Dyspareunia...	84		clinicaltrials.gov
November 3, 2026	NCT07913906	Alberta Cancer Exercise Dose in Colorectal Cancer	University of Calgary	Phase 2	Not yet recruiting	Cancer, Colorectal Cancer	90	Canada	clinicaltrials.gov
November 3, 2026	NCT07913763	Rimonabant for Improving Walking Ability in Patients With Chronic Stroke	Sinfatin S.L	Phase 2	Not yet recruiting	Chronic Stroke	80	Spain	clinicaltrials.gov
November 3, 2026	NCT07913594	Zilovertamab Vedotin and Lenalidomide (ZiVLen) Therapy for Relapsed/Refractory Peripheral T-Cell Lymphoma	Olivia Newton-John Cancer Research Institute	Phase 2	Not yet recruiting	Peripheral T-Cell Lymphoma Refractory	25	Australia	clinicaltrials.gov
November 3, 2026	NCT07913568	A Phase II Investigator-initiated Trial of Sacituzumab Tirumotecan Plus Pembrolizumab in Patients With Recurrent ovarIan Clear Cell...	National Cancer Center, Japan	Phase 2	Not yet recruiting	Ovarian Clear Cell Carcinoma	32	Japan	clinicaltrials.gov
November 3, 2026	NCT07913542	N-Acetylcysteine for Bipolar and Alcohol Use Disorders	Medical University of South Carolina	Phase 2	Not yet recruiting	Bipolar Disorder, Alcohol Use Disorder	70	United States	clinicaltrials.gov
November 3, 2026	NCT07913165	A Study of Trifluridine/Tipiracil (TAS-102) Combined With Nedaplatin for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma...	Tao Zhang	Phase 2	Not yet recruiting	Gastric Cancer (GC)	36		clinicaltrials.gov
November 3, 2026	NCT07913074	A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With...	Tavo Biotherapeutics	Phase 2	Recruiting	Primary Open - Angle Glaucoma (POAG), Ocular Hypertension (OHT)	96	United States	clinicaltrials.gov
November 3, 2026	NCT07912996	Study to Compare GS-1179 Versus Valacyclovir in HSV-2 Seropositive Participants With Recurrent Genital Herpes	Gilead Sciences	Phase 2	Not yet recruiting	HSV-2 Infection	300		clinicaltrials.gov
November 3, 2026	NCT07912957	Neoadjuvant SHR-A1811 ± Adebrelimab in GC/GEJ	Fudan University	Phase 2	Not yet recruiting	Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma	62	China	clinicaltrials.gov
November 3, 2026	NCT07912606	D2 Gastrectomy With or Without Para-Aortic Lymph Node Dissection After Chemoimmunotherapy for Gastric Cancer	The First Affiliated Hospital with Nanjing Medical University	Phase 2	Not yet recruiting	Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma	32	China	clinicaltrials.gov
November 3, 2026	NCT07911995	A Phase 2 Trial to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tegacorat in Male Participants...	Grünenthal GmbH	Phase 2	Not yet recruiting	Duchenne Muscular Dystrophy (DMD)	36		clinicaltrials.gov
November 3, 2026	NCT07911891	Oral Mecobalamin for TKI-Associated Hand-Foot Syndrome in Advanced Thyroid Cancer	Li Zhihui	Phase 2	Completed	Thyroid Cancer, Hand-foot Syndrome	100	China	clinicaltrials.gov
November 3, 2026	NCT07911735	A Study Evaluating the Efficacy and Safety of SYH2072 Tablets In Hypertensive Patients	InnovStone Therapeutics Limited	Phase 2	Not yet recruiting	Uncontrolled Hypertension, Resistant Hypertension	264		clinicaltrials.gov
November 3, 2026	NCT07911683	Study Evaluating the Efficacy and Safety of BGB-B2033 in Participants With Advanced Hepatocellular Carcinoma	BeOne Medicines	Phase 2	Not yet recruiting	Hepatocellular Cancer, Liver Cancer, Hepatocellular Carcinoma	100		clinicaltrials.gov
November 2, 2026	NCT07911449	Osimertinib Plus Stereotactic Radiosurgery/Radiotherapy for EGFR-Mutant Non-Small Cell Lung Cancer With Symptomatic Brain Metastases	Cho Ray Hospital	Phase 2	Recruiting	Non-Small Cell Lung Cancer, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), EGFR Activating Mutation	41	Vietnam	clinicaltrials.gov
November 2, 2026	NCT07911280	A Phase II, Trial of Neoadjuvant Trastuzumab + Durvalumab + FLOT Targeted Immunochemotherapy	Samsung Medical Center	Phase 2	Recruiting	Gastric Cancer	20	South Korea	clinicaltrials.gov
November 2, 2026	NCT07911124	Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease	University of Arkansas	Phase 2	Not yet recruiting	Chronic Kidney Disease (CKD)	230	United States	clinicaltrials.gov
November 2, 2026	NCT07910630	A Study Evaluating the Efficacy and Safety of Recombinant Human Truncated Plasmin Injection (JZB32) in Patients With Vitreomacular Traction	Jiangsu Jingze Biopharmaceutical Co., Ltd.	Phase 2	Recruiting	Vitreomacular Traction (VMT)	48	China	clinicaltrials.gov
November 2, 2026	NCT07910435	Polatuzumab Vedotin, Mosunetuzumab, and Acalabrutinib for the Treatment of Mantle Cell Lymphoma, PAcMan Trial	University of Washington	Phase 2	Not yet recruiting	Mantle Cell Lymphoma	27	United States	clinicaltrials.gov
November 2, 2026	NCT07909889	Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer	Aarhus University Hospital	Phase 2	Not yet recruiting	Breast Cancer (Early Breast Cancer), Obesity	32	Denmark	clinicaltrials.gov
November 2, 2026	NCT07909863	Low-Dose Radiotherapy Plus Adebrelimab and Chemotherapy for Extensive-Stage Small Cell Lung Cancer	Tianjin Medical University Cancer Institute and Hospital	Phase 2	Not yet recruiting	Small Cell Lung Cancer (SCLC), SCLC, Extensive Stage	25	China	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Fudan University	164	November 6, 2026
Sun Yat-sen University	156	November 6, 2026
Tianjin Medical University Cancer Institute and Hospital	116	November 2, 2026
M.D. Anderson Cancer Center	73	November 5, 2026
Institute of Hematology & Blood Diseases Hospital, China	66	November 6, 2026
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	66	November 4, 2026
The First Affiliated Hospital with Nanjing Medical University	66	November 3, 2026
Ruijin Hospital	60	November 5, 2026
Second Affiliated Hospital, Zhejiang University, School of Medicine	57	November 9, 2026
Memorial Sloan Kettering Cancer Center	51	November 5, 2026
Peking Union Medical College Hospital	41	October 16, 2026
Novartis Pharmaceuticals	38	November 6, 2026
Eli Lilly and Company	38	November 6, 2026
Washington University School of Medicine	38	November 3, 2026
Shanghai Zhongshan Hospital	37	November 5, 2026
Merck Sharp & Dohme LLC	37	October 26, 2026
Mayo Clinic	36	November 9, 2026
National Cancer Institute (NCI)	35	November 4, 2026
West China Hospital	35	October 29, 2026
AstraZeneca	35	August 19, 2026

Conditions

Condition group	New trials	Latest
Carcinoma, Non-Small-Cell Lung	275	November 5, 2026
Breast Neoplasms	245	November 5, 2026
Colorectal Neoplasms	151	November 9, 2026
Obesity	141	November 2, 2026
Carcinoma, Hepatocellular	124	November 5, 2026
Prostatic Neoplasms	120	November 9, 2026
Neoplasms	111	November 3, 2026
Recurrence	109	November 6, 2026
Lung Neoplasms	104	October 22, 2026
Squamous Cell Carcinoma of Head and Neck	103	November 9, 2026
Leukemia, Myeloid, Acute	96	November 9, 2026
Overweight	92	November 5, 2026
Stomach Neoplasms	89	November 5, 2026
Triple Negative Breast Neoplasms	87	November 3, 2026
Neoplasm Metastasis	75	October 29, 2026
Pancreatic Neoplasms	72	October 26, 2026
Rectal Neoplasms	72	October 22, 2026
Diabetes Mellitus, Type 2	71	November 6, 2026
Multiple Myeloma	67	October 29, 2026
Head and Neck Neoplasms	66	November 5, 2026
Lymphoma, Large B-Cell, Diffuse	65	November 4, 2026
Uterine Cervical Neoplasms	64	August 18, 2026
Carcinoma, Renal Cell	61	November 9, 2026
Small Cell Lung Carcinoma	61	November 2, 2026
Alzheimer Disease	61	October 29, 2026

By country

Country	New trials	Latest
China	2,502	November 9, 2026
United States	2,201	November 9, 2026
Canada	356	November 9, 2026
France	350	October 20, 2026
Spain	334	November 9, 2026
Italy	264	November 6, 2026
United Kingdom	254	November 3, 2026
Germany	252	November 9, 2026
Australia	247	November 5, 2026
Poland	210	November 6, 2026
South Korea	202	November 9, 2026
Japan	187	November 9, 2026
Egypt	143	November 6, 2026
Taiwan	134	November 3, 2026
Brazil	125	October 29, 2026
Netherlands	123	October 6, 2026
Argentina	106	October 22, 2026
Belgium	102	November 9, 2026
Czechia	84	September 29, 2026
Denmark	76	November 5, 2026
Hungary	75	November 6, 2026
Israel	71	October 26, 2026
Pakistan	63	November 6, 2026
Turkey (Türkiye)	61	September 24, 2026
Greece	61	September 9, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.